Rapid Novor is a leading Contract Research Organization (CRO) specializing in antibody characterization and discovery services powered by mass spectrometry. The company offers innovative solutions such as monoclonal and polyclonal antibody sequencing, epitope mapping, and antibody expression, enabling biotech and pharmaceutical companies to unlock the full potential of antibodies. With a strong focus on next-generation protein sequencing, Rapid Novor has completed over 9000 successful sequencing projects and served more than 650 clients, positioning itself as a key player in the life sciences sector. Their patented technology and expertise in protein chemistry and bioinformatics differentiate them in the market, driving significant advancements in diagnostics and therapeutics.
Something looks off?On-site & Remote